Search Videos and More
Fox Chase Researcher and Former Chief Fellow Presents Findings on 5-Aminolevulinic Acid-Mediated Radiation Therapy to Reduce Tumor Size
“Radiodynamic therapy is a combined treatment technique of photodynamic therapy and radiation therapy that treats cancer using light and radiation,” said Dae-Myoung Yang, PhD, an Assistant Professor in the Department of Radiation Oncology at Fox Chase.A Prolific Career. An Auspicious Beginning.
As a genitourinary medical oncologist at Johns Hopkins, Jean Hoffman-Censits, MD, Associate Professor of Oncology and Urology, focuses on urothelial cancers of the bladder and upper tract, particularly women’s bladder cancer, which is often more aggressive than in men.Fox Chase Vision Illuminated by Real Nurses and Real Patients
When asked to present the keynote at this year’s ONA Summit, Real Nurses, Real Solutions: Breakthrough Strategies in Oncology Nursing Practice, Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer and Vice President, Nursing and Patient Care Services at Fox Chase Cancer Center, had the Fox Chase nursing staff, support staff, and patients bring the theme to life in a heartfelt video, demonstrating Fox Chase's vision and values.Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Fox Chase Researchers Present Data on Integrating Palliative Care Education Into Hematology-Oncology Fellowships
A new integrated palliative care rotation for hematology/oncology fellows improved their palliative care knowledge and skill confidence, according to results of a pilot study presented today by Fox Chase Cancer Center researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.Putting the Nurse Back into Nurse Navigation
More than 15 years ago, Fox Chase Cancer Center launched a Nurse Navigation system to expedite the journey through complex cancer care with experienced oncologic nurses as a patient’s first 'point-of-contact' via phone.Harnessing the Power of Adaptive Radiation Therapy: A One-Year Review from Fox Chase Cancer Center
Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly moved adaptive radiation therapy into the mainstream, demonstrating its clinical advantages for treating prostate, bladder, liver, pancreas, breast, lung, and head and neck cancers.Fox Chase Researcher’s Presentation Highlights Unique Approach to Esophagectomy at American College of Surgeons Clinical Congress
Nosayaba Enofe, MD, presented his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.New Medical Oncology Leadership Advances Clinical Care, Research, Discovery, and Delivery at Temple Health and Fox Chase
For Fox Chase Cancer Center and the larger Temple Health community, the appointment of Martin Edelman, MD, is an exciting new opportunity to collaborate and integrate cancer care within these two institutions.We All Rise Together: Dr. Camille Ragin's Vision for Health Equity in Cancer
The statistics are riveting: Throughout the world, approximately 17 percent of the human population are individuals of African descent.A More Accurate, Less Invasive Analysis for Lung Cancers: RNA Next-Generation Sequencing
Genetically targeted therapy for lung cancer can make treatment much more effective, but identifying the specific gene fusions involved in the disease remains a challenge.Research on Making Cancer “Catch” the Flu Wins International Acclaim in Nature
Turning a "cold" tumor "hot" to fight advanced melanoma.